Among our group of FH patients treated in lipid outpatient clinics in the southeastern part of Poland, 38.29% had Lp(a) levels above 0.3 g/L, and 28.3% had Lp(a) levels above 0.5 g/L. This evidence concerns the gene LPA and familial hyperaldosteronism.